mhurhangee/ep-ind-claims huggingface dataset:
A system comprising: a wearable device configured to output information related to an event generated in one application operable in a mobile terminal, the event being sensed by the wearable device, wherein the wearable device is further configured to display a notification icon guiding the presence of an attached file on a display unit of the wearable device; and the mobile terminal including a touch screen configured to display an execution screen of a function linked to the generated event in response to a tap meeting a preset condition being input on the touch screen by a user wearing the wearable device, wherein the generated event is receiving a message including an attached file, the function is executing the attached file, wherein when the tap meeting a preset condition being input on the touch screen by the user wearing the wearable device is input while the notification icon is output on the display unit of the wearable device, the execution screen of the attached file is displayed on the touch screen and contents of the received message along with the attached file are displayed on the display of the wearable device. a wearable device configured to output information related to an event generated in one application operable in a mobile terminal, the event being sensed by the wearable device, wherein the wearable device is further configured to display a notification icon guiding the presence of an attached file on a display unit of the wearable device; and the mobile terminal including a touch screen configured to display an execution screen of a function linked to the generated event in response to a tap meeting a preset condition being input on the touch screen by a user wearing the wearable device, wherein the generated event is receiving a message including an attached file, the function is executing the attached file, wherein when the tap meeting a preset condition being input on the touch screen by the user wearing the wearable device is input while the notification icon is output on the display unit of the wearable device, the execution screen of the attached file is displayed on the touch screen and contents of the received message along with the attached file are displayed on the display of the wearable device.
A power supply frequency determination device, comprising: a voltage detection means configured to detect a DC voltage converted from AC power by a converter; a voltage determination means configured to determine whether or not the DC voltage detected by the voltage detection means enters within a predetermined reference voltage range, at time intervals corresponding to an assumed value for a frequency of the AC power; and a frequency determination means configured to determine a validity of the assumed value, based on a number of times that the DC voltage is determined as having entered within the reference voltage range by the voltage determination means, within a time range corresponding to the assumed value. a voltage detection means configured to detect a DC voltage converted from AC power by a converter; a voltage determination means configured to determine whether or not the DC voltage detected by the voltage detection means enters within a predetermined reference voltage range, at time intervals corresponding to an assumed value for a frequency of the AC power; and a frequency determination means configured to determine a validity of the assumed value, based on a number of times that the DC voltage is determined as having entered within the reference voltage range by the voltage determination means, within a time range corresponding to the assumed value.
A water-free liposome suspension comprising: an adjuvant that activates or increases the activity of toll-like receptor 2 and liposomes containing an antigen, reconstituted in a carrier comprising a continuous phase of a hydrophobic substance; wherein the antigen is capable of inducing a humoral immune response; and wherein the adjuvant comprises dipalmitoyl-S-glyceryl-cysteine (PAM 2 Cys) or tripalmitoyl-S-glyceryl-cysteine (PAM 3 Cys). an adjuvant that activates or increases the activity of toll-like receptor 2 and liposomes containing an antigen, reconstituted in a carrier comprising a continuous phase of a hydrophobic substance; wherein the antigen is capable of inducing a humoral immune response; and wherein the adjuvant comprises dipalmitoyl-S-glyceryl-cysteine (PAM 2 Cys) or tripalmitoyl-S-glyceryl-cysteine (PAM 3 Cys).
Measuring device for at least one physical quantity, the measuring device comprising at least: - a transceiver unit for electromagnetic waves, - an antenna-sensor consisting of a sensor integrated into a target antenna having at least one excitation port, the antenna-sensor having a variable impedance with electromagnetic transduction, characterized in that, per predetermined frequency band and independently of an angular deviation between the transmission and the reception of waves, the measuring device is configured to measure an electromagnetic response of the antenna-sensor at least from an ellipticity rate of an electromagnetic field backscattered by said antenna-sensor, the ellipticity rate characterizing the polarization of the electromagnetic field configured to be measured by said transceiver unit, said electromagnetic response being representative, by electromagnetic transduction, of said at least one physical quantity to be measured. - a transceiver unit for electromagnetic waves, - an antenna-sensor consisting of a sensor integrated into a target antenna having at least one excitation port, the antenna-sensor having a variable impedance with electromagnetic transduction,
A rotor (10, 150) for a centrifuge, comprising: a rotor body (22, 152) defining a plurality of first receptacles (140, 194) spaced circumferentially about an axis of rotation of the rotor body (22, 152), a plurality of adapters (18, 154) each configured to receive a processing container (142, 156) and to engage a respective first receptacle (140, 194) so that each adapter (18, 154) is held in place within the rotor (10, 150) by the respective first receptacle (140, 194), characterized by: a rotor liner including a plurality of second receptacles placed circumferentially about the axis of rotation of the rotor body (22, 152), each second receptacle being configured to be received by a respective one of the first receptacles (140, 194). a rotor body (22, 152) defining a plurality of first receptacles (140, 194) spaced circumferentially about an axis of rotation of the rotor body (22, 152), a plurality of adapters (18, 154) each configured to receive a processing container (142, 156) and to engage a respective first receptacle (140, 194) so that each adapter (18, 154) is held in place within the rotor (10, 150) by the respective first receptacle (140, 194), characterized by: a rotor liner including a plurality of second receptacles placed circumferentially about the axis of rotation of the rotor body (22, 152), each second receptacle being configured to be received by a respective one of the first receptacles (140, 194).
A microfluidic mixing device (100A, 100B, 100C, 200, 300, 400), comprising: a first bellows pump (B1, 105) with a chamber bisected in coronal plane by a first elastomeric membrane; a second bellows pump (B2, 115) with a chamber bisected in coronal plane by a second elastomeric membrane; a first microchannel fluidly interconnecting the first bellows pump (B1, 105) with a sample inlet and a reagent reservoir, wherein the first microchannel comprises a valve interposed between the pump and the inlet and a valve interposed between the pump (B1, 105) and the reservoir; a second microchannel fluidly interconnecting the first bellows pump (B1, 105) with the second bellows pump (B2, 115), wherein the second micro channel comprises a valve interposed between the first and second pump; a first and second pneumatic member pneumatically connected to the first and second bellows pumps (B1, 105, B2, 115); characterized in that the microfluidic mixing device (100A, 100B, 100C, 200, 300, 400) further comprises a third microchannel fluidly interconnecting the first bellows pump (B1, 105) with the second bellows pump (B2, 115), wherein the third micro channel comprises a valve interposed between the first and second pump; and in that the volume of the second bellows pump (B2, 115) is greater than the volume of the first bellows pump (B1, 105). a first bellows pump (B1, 105) with a chamber bisected in coronal plane by a first elastomeric membrane; a second bellows pump (B2, 115) with a chamber bisected in coronal plane by a second elastomeric membrane; a first microchannel fluidly interconnecting the first bellows pump (B1, 105) with a sample inlet and a reagent reservoir, wherein the first microchannel comprises a valve interposed between the pump and the inlet and a valve interposed between the pump (B1, 105) and the reservoir; a second microchannel fluidly interconnecting the first bellows pump (B1, 105) with the second bellows pump (B2, 115), wherein the second micro channel comprises a valve interposed between the first and second pump; a first and second pneumatic member pneumatically connected to the first and second bellows pumps (B1, 105, B2, 115); characterized in that the microfluidic mixing device (100A, 100B, 100C, 200, 300, 400) further comprises a third microchannel fluidly interconnecting the first bellows pump (B1, 105) with the second bellows pump (B2, 115), wherein the third micro channel comprises a valve interposed between the first and second pump; and in that the volume of the second bellows pump (B2, 115) is greater than the volume of the first bellows pump (B1, 105).
A method for preparing a modified beta-stucco from calcined natural rock gypsum comprising: preparing a solution of liquid diethylene-triamine-pentaacetic acid in water; applying the solution onto said beta-stucco while hot from the calciner, forming a wetted stucco; and allowing the wetted stucco to dry and heal, forming the modified beta-stucco. preparing a solution of liquid diethylene-triamine-pentaacetic acid in water; applying the solution onto said beta-stucco while hot from the calciner, forming a wetted stucco; and allowing the wetted stucco to dry and heal, forming the modified beta-stucco.
Apparatus for the treatment of a brain affection, in particular brain tumor, characterized in that it comprises at least one MRI compatible implantable generator made of non-ferromagnetic material for implantation into a burr-hole performed in the skull of a patient, said implantable generator comprising: - a casing having at least an upper wall, and a lower wall connected together by a peripheral wall, - an ultrasound generating treating device positioned into said casing to induce brain affection treatment by emission of ultrasound waves through its lower wall into the brain with an emission frequency between 200 kHz and 10 MHz, and preferably 1 MHz, and - means (5, 12,12') for fastening the implantable casing into the skull, characterized by said apparatus further comprising: - a power controller (PwC) to supply electricity to the treating device of the implantable generator and to set and control its working parameters, and - connecting means to connect the power controller and the treating device of the implantable generator; - connecting plugs to accommodate the connecting means and assure connection between the power controller (PwC) and the treating device, - the connecting plugs being transdermic plugs held into the upper wall of the casing of the implantable generator and comprising an isolating coating preventing contact with the patient's skin, and - connecting means comprising transdermic needles suitable for plugging into the connecting plugs through the patient's skin, said transdermic needles being coated with an isolating material except at their tip for contacting the treating device connectors through the connecting plugs. - a casing having at least an upper wall, and a lower wall connected together by a peripheral wall, - an ultrasound generating treating device positioned into said casing to induce brain affection treatment by emission of ultrasound waves through its lower wall into the brain with an emission frequency between 200 kHz and 10 MHz, and preferably 1 MHz, and - means (5, 12,12') for fastening the implantable casing into the skull, - a power controller (PwC) to supply electricity to the treating device of the implantable generator and to set and control its working parameters, and - connecting means to connect the power controller and the treating device of the implantable generator; - connecting plugs to accommodate the connecting means and assure connection between the power controller (PwC) and the treating device, - the connecting plugs being transdermic plugs held into the upper wall of the casing of the implantable generator and comprising an isolating coating preventing contact with the patient's skin, and - connecting means comprising transdermic needles suitable for plugging into the connecting plugs through the patient's skin, said transdermic needles being coated with an isolating material except at their tip for contacting the treating device connectors through the connecting plugs.
Method for controlling a piezoelectric motor by way of at least two driving electrodes (11, 12) by applying periodic control voltages to said driving electrodes (11, 12), where in a first step of the method said periodic control voltages (U 11, U 12)) are applied with a phase shift to said driving electrodes (11, 12), and in a second step of the method, the amplitude ratio of said periodic control voltages (U 11, U 12) is changed with respect to the first step, characterized in that, in the first step of the method the phase shift and/or the amplitude ratio of said periodic control voltages (U 11, U 12) is/are adjusted such that the static friction of said friction contact between a friction element of said piezoelectric motor and an output element to be driven by said friction element is reduced without creating a propulsion of said output element at the same time, wherein no deflecting forces are applied to said output element and said output element is in force equilibrium along its degrees of freedom of movement, and in that, in the second step of the method, the phase shift and/or the amplitude ratio of said periodic control voltages (U 11, U 12) is/are changed in such a way with regard to the first step that the vibration path of said friction element inclines as compared to the first step and thereby produces a propulsion of said output element.
Process for the preparation of doped pentasil-type zeolite, comprising the steps of: a) preparing an aqueous precursor mixture comprising a silicon source, an aluminium source, doped faujasite seeds, and another type of seeding material comprising pentasil-type seeds, and b) thermally treating the precursor mixture to form a doped pentasil-type zeolite. a) preparing an aqueous precursor mixture comprising a silicon source, an aluminium source, doped faujasite seeds, and another type of seeding material comprising pentasil-type seeds, and b) thermally treating the precursor mixture to form a doped pentasil-type zeolite.
Bicycle handlebar support, in particular for time trial bicycles or triathlon bicycles, comprising a central holding element directed in the traveling direction when in the mounted state, two arm supports, each arranged laterally beside the holding element, and a single common grip element arranged at a front portion of the single holding element, wherein for a simultaneous gripping with both hands, the grip element is designed in particular to be asymmetric to a longitudinal direction, wherein the hands partially overlap in a gripping position,. characterized in that the grip element has two, in particular opposite thumb support regions on its upper side, and wherein at least one switch element (6, 7) is provided between and/or below the thumb support regions. a central holding element directed in the traveling direction when in the mounted state, two arm supports, each arranged laterally beside the holding element, and a single common grip element arranged at a front portion of the single holding element, wherein for a simultaneous gripping with both hands, the grip element is designed in particular to be asymmetric to a longitudinal direction, wherein the hands partially overlap in a gripping position,. characterized in that the grip element has two, in particular opposite thumb support regions on its upper side, and wherein at least one switch element (6, 7) is provided between and/or below the thumb support regions.
A sensor chip (1, 1001) comprising: a substrate that has a planar portion; and a diffraction grating on which a target substance can be placed, wherein the diffraction grating is formed on the planar portion, has a surface formed from a metal, and includes: - a plurality of first protrusions periodically arranged in a period equal to or greater than 100 nm and equal to or less than 1000 nm in a first direction that is parallel to the planar portion, - a plurality of base portions, each of which is located between two of the first protrusions adjacent to each other, wherein the base portions form a base of the substrate, - a plurality of second protrusions formed on an upper face of each of the plurality of the first protrusions, and - a plurality of third protrusions formed on each of the plurality of base portions characterized in that the plurality of the first protrusions is periodically arranged in a second direction that intersects with the first direction and is parallel to the planar portion. a substrate that has a planar portion; and a diffraction grating on which a target substance can be placed, wherein the diffraction grating is formed on the planar portion, has a surface formed from a metal, and includes: - a plurality of first protrusions periodically arranged in a period equal to or greater than 100 nm and equal to or less than 1000 nm in a first direction that is parallel to the planar portion, - a plurality of base portions, each of which is located between two of the first protrusions adjacent to each other, wherein the base portions form a base of the substrate, - a plurality of second protrusions formed on an upper face of each of the plurality of the first protrusions, and - a plurality of third protrusions formed on each of the plurality of base portions characterized in that the plurality of the first protrusions is periodically arranged in a second direction that intersects with the first direction and is parallel to the planar portion. - a plurality of first protrusions periodically arranged in a period equal to or greater than 100 nm and equal to or less than 1000 nm in a first direction that is parallel to the planar portion, - a plurality of base portions, each of which is located between two of the first protrusions adjacent to each other, wherein the base portions form a base of the substrate, - a plurality of second protrusions formed on an upper face of each of the plurality of the first protrusions, and - a plurality of third protrusions formed on each of the plurality of base portions
A method for the detection of SARS-CoV-2 RNA viruses of the family Coronaviridae, comprising - coupling a binding agent selected from the group consisting of an angiotensin-converting enzyme 2, an ACE2 construct, an ACE2 fusion protein, or a modified or mutant ACE2 polypeptide or ACE2 fusion protein that is capable of binding to a virus component of said SARS-CoV-2 RNA virus of the family Coronaviridae to beads, - incubating the beads with the thereon coupled binding agent with a SARS-CoV-2 virus-containing sample, - staining the viruses immobilised on the beads with a staining agent for viral RNA, - detecting stained virus particles via a physical, chemical or biological detection means. - coupling a binding agent selected from the group consisting of an angiotensin-converting enzyme 2, an ACE2 construct, an ACE2 fusion protein, or a modified or mutant ACE2 polypeptide or ACE2 fusion protein that is capable of binding to a virus component of said SARS-CoV-2 RNA virus of the family Coronaviridae to beads, - incubating the beads with the thereon coupled binding agent with a SARS-CoV-2 virus-containing sample, - staining the viruses immobilised on the beads with a staining agent for viral RNA, - detecting stained virus particles via a physical, chemical or biological detection means.
Composite elements comprising (a) thermoplastic with, adhering thereto, (b) the product of the reaction of a reaction mixture composed of (i) one or more isocyanates, (ii) one or more polyester polyols with functionality of from 2.5 to 3.5 and a hydroxy number of from 40 to 400 mg KOH/g based on the condensation of succinic acid with diols with molar mass of from 62 to 200 g/mol and triols with molar mass of from 62 to 200 g/mol, (iii) one or more polyether polyols, and optionally (iv) chain extenders and/or crosslinking agents, optionally in the presence of (v) catalysts, (vi) blowing agents and/or (vii) auxiliaries and/or additives.
A secondary battery, comprising a positive electrode plate and a negative electrode plate, the positive electrode plate comprising a positive electrode current collector and a positive electrode film that is disposed on at least one surface of the positive electrode current collector and comprises a positive active material, the negative electrode plate comprising a negative electrode current collector and a negative electrode film that is disposed on at least one surface of the negative electrode current collector and comprises a negative active material, wherein the positive active material comprises one or more of layered lithium transition metal oxides and modified compounds thereof, and the "modified compounds thereof' means that the layered lithium transition metal oxides are modified by doping and/or surface coating; the negative active material comprises a first material and a second material, the first material comprises artificial graphite, the second material comprises natural graphite, and the negative electrode plate has a resistance R satisfying 8.5 mΩ ≤ R ≤ 12.0 mQ as measured according to the method in the description. wherein the positive active material comprises one or more of layered lithium transition metal oxides and modified compounds thereof, and the "modified compounds thereof' means that the layered lithium transition metal oxides are modified by doping and/or surface coating; the negative active material comprises a first material and a second material, the first material comprises artificial graphite, the second material comprises natural graphite, and the negative electrode plate has a resistance R satisfying 8.5 mΩ ≤ R ≤ 12.0 mQ as measured according to the method in the description.
A oncolytic virus and a STAT1/3 inhibitor for use in a method of treating cancer, comprising simultaneous or sequential administration of the oncolytic virus and a STAT1/3 inhibitor, wherein said inhibitor is Nifuroxazide, C16, or a derivative or analog thereof.